← Back to CORT

CORCEPT THERAPEUTICS INC financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 29/07/2026Mar 2026Filed 29/07/2026Sep 2025Filed 04/11/2025Jun 2025Filed 29/07/2026Mar 2025Filed 29/07/2026Sep 2024Filed 04/11/2025Jun 2024Filed 04/11/2025Mar 2024Filed 04/11/2025
$256$165$208$194$157$183$164$147
$43−$32$20$35$21$47$35$28
$0.36−$0.30$0.16$0.29$0.17$0.41$0.32$0.25
118104119120120114111110

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.